VVUS VIVUS Inc.

$0.401 -5.13%

130,641 Shares Traded
647,789 Average Volume (last 30 days)

as of April 19, 2018 EST IEX Real-Time Price

Free Newsletter Sign Up

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $115.89 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:23.36%
If Intiated One Month Ago, Shorts Have Realized a Return of:4.91%
If Initiated Five Days ago, Shorts Have Realized a Return of:5.2%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 5.16%
Short Interest5.34 million
Float103.41 million
Short Ratio7.16
Market Cap$42.51 million
Market Maker ActivityDaily Short Volume

News

03-24-2018
Novo Nordisk Can Succeed In Weight Loss Where Orexigen, Vivus, Arena Failed (SeekingAlpha)
03-19-2018
Orexigen Files For Bankruptcy - Investors Need To Get Savvy (SeekingAlpha)
03-13-2018
Vivus beats by $0.03, misses on revenue (SeekingAlpha)
01-05-2018
Your Daily Pharma Scoop: ChemoCentryx Surges, Akebia Gets Positive News, Atara Prices Public Offering (SeekingAlpha)
12-28-2017
Your Daily Pharma Scoop: Portola BLA Review Process Delayed, DelMar Soars, Alexion Gets Nod For Soliris In Japan (SeekingAlpha)
12-26-2017
Vivus CEO stepping down (SeekingAlpha)
11-07-2017
Vivus' (VVUS) CEO Seth Fischer on Q3 2017 Results - Earnings Call Transcript (SeekingAlpha)
11-07-2017
Vivus beats by $0.07, misses on revenue (SeekingAlpha)
10-05-2017
Your Daily Pharma Scoop: The First Trust NYSE Arca Biotechnology Index, Gilead's Single Pill, Acadia's New Trial (SeekingAlpha)
09-06-2017
VIVUS' tacrolimus an Orphan Drug in Europe for pulmonary arterial hypertension (SeekingAlpha)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 24.5%
Insider Percent2.5%

Earnings Stats

PE Ratio -1.34
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $0.71
50 Day Moving Average $0.44
52 Week High $1.38
52 Week Low $0.33



Data provided for free by IEX. Questions? Read the FAQ